NEW YORK (GenomeWeb) — Qiagen said this week that it plans to relaunch its GeneReader next-generation sequencing system in the US after developing a new sequencing chemistry that it believes circumnavigates intellectual property constraints placed on the current chemistry by a legal dispute with Illumina.

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.

This webinar will demonstrate how a research team at the Firestone Institute for Respiratory Health at McMaster University developed a cellular and molecular phenotyping pipeline using archived samples of lung tissue derived from patients diagnosed with fibrotic interstitial lung disease.